Exogenus Therapeutics

About Exogenus Therapeutics

The startup has developed an exosome-based platform that utilizes proprietary vesicles with regenerative, anti-inflammatory, and immunomodulatory properties to create therapeutic products. This technology provides healthcare providers with targeted treatment options for skin and autoimmune diseases.

What does Exogenus Therapeutics do?

The startup has developed an exosome-based platform that utilizes proprietary vesicles with regenerative, anti-inflammatory, and immunomodulatory properties to create therapeutic products. This technology provides healthcare providers with targeted treatment options for skin and autoimmune diseases.

Where is Exogenus Therapeutics located?

Exogenus Therapeutics is based in Cantanhede, Portugal.

When was Exogenus Therapeutics founded?

Exogenus Therapeutics was founded in 2015.

How much funding has Exogenus Therapeutics raised?

Exogenus Therapeutics has raised 980000.

Location
Cantanhede, Portugal
Founded
2015
Funding
980000
Employees
15 employees
Major Investors
EASME

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Exogenus Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup has developed an exosome-based platform that utilizes proprietary vesicles with regenerative, anti-inflammatory, and immunomodulatory properties to create therapeutic products. This technology provides healthcare providers with targeted treatment options for skin and autoimmune diseases.

exogenus-t.com3K+
cb
Crunchbase
Founded 2015 – Cantanhede, Portugal

Funding

$

Estimated Funding

$500K+

Major Investors

EASME

Team (15+)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.